Taylor Devices, Inc. reported fiscal 2026 second‑quarter sales of $11.6 million, a 36% year‑over‑year increase from $8.55 million in Q2 FY25. First‑half sales rose to $21.5 million, up 7% from $20.17 million in the prior year’s first half, reflecting sustained demand across its product lines.
Net earnings for the quarter reached $2.01 million, a 90% jump from $1.06 million in Q2 FY25, while first‑half net earnings climbed to $4.20 million from $3.72 million. Earnings per share rose to $0.64 in the quarter and $1.33 for the first half, driven by higher sales volume and disciplined cost management. The sharp earnings growth outpaced revenue growth, indicating improving margin efficiency.
The firm’s order backlog stood at $25.1 million at quarter‑end, slightly below the $27.1 million at the start of FY26. Management attributed the decline to order‑receipt timing versus delivery variability, suggesting that the backlog is still robust and that future revenue will be supported by the current pipeline.
Segment analysis shows that demand in the Aerospace/Defense market continued to grow, offsetting headwinds in the Structural and Industrial segments. The strong Aerospace/Defense performance helped maintain overall sales momentum while the other segments faced macro‑economic pressures that slowed growth.
A newly completed Development Lab will support future growth initiatives, underscoring the company’s commitment to research and development and its focus on expanding product capabilities.
Overall, the results demonstrate a significant earnings beat, margin expansion, and a resilient business model. The company’s ability to grow revenue, improve profitability, and invest in future capabilities positions it well for sustained performance in the coming quarters.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.